State of New Jersey Common Pension Fund D Cuts Holdings in Tenet Healthcare Corporation $THC

State of New Jersey Common Pension Fund D decreased its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 8.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,385 shares of the company’s stock after selling 2,789 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Tenet Healthcare were worth $5,839,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Wedmont Private Capital grew its position in Tenet Healthcare by 2.5% in the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock worth $422,000 after acquiring an additional 50 shares in the last quarter. Baron Wealth Management LLC grew its position in Tenet Healthcare by 4.8% in the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after acquiring an additional 52 shares in the last quarter. Sagespring Wealth Partners LLC grew its position in Tenet Healthcare by 3.6% in the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock worth $313,000 after acquiring an additional 55 shares in the last quarter. Crestwood Advisors Group LLC grew its position in Tenet Healthcare by 2.5% in the third quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock worth $529,000 after acquiring an additional 64 shares in the last quarter. Finally, Signaturefd LLC grew its position in Tenet Healthcare by 9.0% in the fourth quarter. Signaturefd LLC now owns 798 shares of the company’s stock worth $159,000 after acquiring an additional 66 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Down 0.0%

Shares of NYSE:THC opened at $183.23 on Monday. Tenet Healthcare Corporation has a 1 year low of $145.27 and a 1 year high of $247.21. The business has a 50 day simple moving average of $207.31 and a two-hundred day simple moving average of $204.33. The firm has a market capitalization of $16.05 billion, a PE ratio of 9.53, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the previous year, the business earned $4.36 earnings per share. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 17.42 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently commented on THC. Weiss Ratings reiterated a “buy (b-)” rating on shares of Tenet Healthcare in a research report on Friday, March 27th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Truist Financial boosted their target price on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Finally, Barclays boosted their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $241.94.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 earnings beat and solid profitability — Tenet reported $4.82 EPS, well ahead of consensus, and showed healthy margins and ROE; investors favor the earnings beat even though revenue was roughly in-line. Tenet Healthcare (THC) Q1 Earnings Top Estimates
• Positive Sentiment: Strategic growth via ASC acquisitions — Tenet deployed ~$125M to acquire seven ambulatory surgery centers in Q1 and signals more M&A in the outpatient space, supporting revenue diversification and higher-margin outpatient growth. Tenet deployed $125M on 7 ASC acquisitions in Q1, eyes more deals
• Positive Sentiment: Operational momentum in procedures and robotics — The company is seeing double?digit joint replacement growth and expanding robotic programs across ASCs/hospitals, evidence that its outpatient acuity push is producing revenue mix benefits longer term. Double-digit joint replacement growth
• Neutral Sentiment: Analysts trimmed price targets but kept Buy/Outperform/Overweight ratings — Multiple firms cut PTs (RBC to $236, Guggenheim to $252, Wells Fargo to $213, KeyCorp to $225) while retaining positive ratings, which gives the stock continued sell?side endorsement but signals more conservative valuation assumptions. Analyst price target coverage (Benzinga summaries) TickerReport coverage
• Neutral Sentiment: Market commentary and investor takeaways — Several pieces are advising investors to weigh analyst views and the company’s outpatient strategy at current levels; these articles are shaping investor positioning rather than delivering new fundamental news. Seeking Alpha: Investor commentary
• Negative Sentiment: Revenue softness and admissions?mix headwinds — Management flagged admissions mix and external disruptions as reasons revenue missed expectations modestly; that weak revenue signal tempers the EPS beat and is the main near-term risk. Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales

Insider Activity at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the sale, the executive vice president owned 12 shares of the company’s stock, valued at $2,866.20. The trade was a 99.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 46,517 shares of company stock worth $10,943,111. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.